contraindications for glp-1 Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force GLP-1 receptor agonists are transforming
Description
Eat on a schedule
The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status
BMI SD score change from 3.49 to 3.17)
Losing a substantial fraction of it in the process of achieving weight loss is, in metabolic terms, trading one problem for another
Anatomy of the normal upper gastrointestinal tract (left) and after Roux-en-Y gastric bypass and sleeve gastrectomy
